-
1
-
-
37049053957
-
Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode
-
B. Rosenberg, L. VanCamp, and T. Krigas Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode Nature 205 1965 698 699
-
(1965)
Nature
, vol.205
, pp. 698-699
-
-
Rosenberg, B.1
Vancamp, L.2
Krigas, T.3
-
2
-
-
0346059586
-
Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice
-
N. Nishiyama, S. Okazaki, H. Cabral, M. Miyamoto, Y. Kato, and Y. Sugiyama Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice Cancer Res 63 2003 8977 8983
-
(2003)
Cancer Res
, vol.63
, pp. 8977-8983
-
-
Nishiyama, N.1
Okazaki, S.2
Cabral, H.3
Miyamoto, M.4
Kato, Y.5
Sugiyama, Y.6
-
3
-
-
79954625512
-
A phase i clinical trial of safingolin combination with cisplatin in advanced solid tumors
-
M.A. Dickson, R.D. Carvajal, A.H. Merrill, M. Gonen, L.M. Cane, and G.K. Schwartz A phase I clinical trial of safingolin combination with cisplatin in advanced solid tumors Clin Cancer Res 17 2011 2484 2492
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2484-2492
-
-
Dickson, M.A.1
Carvajal, R.D.2
Merrill, A.H.3
Gonen, M.4
Cane, L.M.5
Schwartz, G.K.6
-
4
-
-
78650893647
-
Cellular responses to cisplatin-induced DNA damage
-
A. Basu, and S. Krishnamurthy Cellular responses to cisplatin-induced DNA damage J Nucleic Acids 2010 201367
-
(2010)
J Nucleic Acids
, pp. 201367
-
-
Basu, A.1
Krishnamurthy, S.2
-
5
-
-
79953700297
-
Cisplatin as an anti-tumor drug: Cellular mechanism so factivity, drug resistance and induced side effects
-
A. Florea, and D. Busselberg Cisplatin as an anti-tumor drug: cellular mechanism so factivity, drug resistance and induced side effects Cancer 3 2011 1351 1371
-
(2011)
Cancer
, vol.3
, pp. 1351-1371
-
-
Florea, A.1
Busselberg, D.2
-
6
-
-
83255171142
-
Global phosphor proteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells
-
A. Pines, C.D. Kelstrup, M.G. Vrouwe, J.C. Puigvert, D. Typas, and B. Misovic Global phosphor proteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells Mol Cell Biol 31 2011 4964 4977
-
(2011)
Mol Cell Biol
, vol.31
, pp. 4964-4977
-
-
Pines, A.1
Kelstrup, C.D.2
Vrouwe, M.G.3
Puigvert, J.C.4
Typas, D.5
Misovic, B.6
-
7
-
-
0021435857
-
Drugs five years later cisplatin
-
P.J. Loehrer, and L.H. Einhorn Drugs five years later cisplatin Ann Intern Med 100 1984 704 713
-
(1984)
Ann Intern Med
, vol.100
, pp. 704-713
-
-
Loehrer, P.J.1
Einhorn, L.H.2
-
8
-
-
84860992007
-
Choosing the right cell line for breast cancer research
-
D.L. Holliday, and V. Speirs Choosing the right cell line for breast cancer research Breast Cancer Res 13 2011 215
-
(2011)
Breast Cancer Res
, vol.13
, pp. 215
-
-
Holliday, D.L.1
Speirs, V.2
-
9
-
-
65549088535
-
Interferon-beta therapy monitoring in multiple sclerosis patients
-
A. Sottini, R. Capra, F. Serana, M. Chiarini, L. Caimi, and L. Imberti Interferon-beta therapy monitoring in multiple sclerosis patients Endocr Metab Immune Disord Drug Targets 9 2009 14 28
-
(2009)
Endocr Metab Immune Disord Drug Targets
, vol.9
, pp. 14-28
-
-
Sottini, A.1
Capra, R.2
Serana, F.3
Chiarini, M.4
Caimi, L.5
Imberti, L.6
-
10
-
-
34347259525
-
IL-28 and IL-29: Newcomers to the interferon family
-
G. Uze, and D. Monneron IL-28 and IL-29: newcomers to the interferon family Biochimie 89 2007 729 734
-
(2007)
Biochimie
, vol.89
, pp. 729-734
-
-
Uze, G.1
Monneron, D.2
-
11
-
-
77956187466
-
Human umbilical cord matrix derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice
-
T. Matsuzuka, R.S. Rachakatla, C. Doi, D.K. Maurya, N. Ohta, and A. Kawabata Human umbilical cord matrix derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice Lung Cancer 70 2009 28 36
-
(2009)
Lung Cancer
, vol.70
, pp. 28-36
-
-
Matsuzuka, T.1
Rachakatla, R.S.2
Doi, C.3
Maurya, D.K.4
Ohta, N.5
Kawabata, A.6
-
12
-
-
9644262469
-
Interferons, interferon like cytokines, and their receptors
-
S. Pestka, C.D. Krause, and M.R. Walter Interferons, interferon like cytokines, and their receptors Immunol Rev 202 2004 8 32
-
(2004)
Immunol Rev
, vol.202
, pp. 8-32
-
-
Pestka, S.1
Krause, C.D.2
Walter, M.R.3
-
13
-
-
11044230488
-
Interferon-β gene therapy for cancer: Basic research to clinical application
-
J. Yoshida, M. Mizuno, and T. Wakabayashi Interferon-β gene therapy for cancer: basic research to clinical application Cancer Sci 95 2004 858 865
-
(2004)
Cancer Sci
, vol.95
, pp. 858-865
-
-
Yoshida, J.1
Mizuno, M.2
Wakabayashi, T.3
-
14
-
-
57249107928
-
A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes
-
K. Matsumoto, H. Kubo, H. Murata, H. Uhara, M. Takata, and S. Shibata A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes Jpn J Clin Oncol 38 2008 849 856
-
(2008)
Jpn J Clin Oncol
, vol.38
, pp. 849-856
-
-
Matsumoto, K.1
Kubo, H.2
Murata, H.3
Uhara, H.4
Takata, M.5
Shibata, S.6
-
15
-
-
0028345187
-
Long-term follow-up results of 175 patients with malignant glioma: Importance of radical tumor resection and post-operative adjuvant therapy with interferon, ACNU and radiation
-
J. Yoshida, Y. Kajita, T. Wakabayashi, and K. Sugita Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumor resection and post-operative adjuvant therapy with interferon, ACNU and radiation Acta Neurochir 127 1994 55 59
-
(1994)
Acta Neurochir
, vol.127
, pp. 55-59
-
-
Yoshida, J.1
Kajita, Y.2
Wakabayashi, T.3
Sugita, K.4
-
16
-
-
1542753740
-
Interferon-b is more potent than interferon-a in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs
-
B. Damdinsuren, H. Nagano, M. Sakon, M. Kondo, and T. Yamamoto Interferon-b is more potent than interferon-a in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs Ann Surg Oncol 10 2003 1184 1190
-
(2003)
Ann Surg Oncol
, vol.10
, pp. 1184-1190
-
-
Damdinsuren, B.1
Nagano, H.2
Sakon, M.3
Kondo, M.4
Yamamoto, T.5
-
17
-
-
84881595858
-
Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells
-
Q. Li, K. Kawamura, S. Yang, S. Okamoto, and H. Kobayashi Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells PLoS One 8 8 2013 e72709
-
(2013)
PLoS One
, vol.8
, Issue.8
, pp. 72709
-
-
Li, Q.1
Kawamura, K.2
Yang, S.3
Okamoto, S.4
Kobayashi, H.5
-
18
-
-
0032774272
-
Efficacy of treatment of colon, lung and breast human carcinoma xenografts with: Doxorubicin, cisplatin, irinotecan or topotecan
-
W.E. Hardman, M.P. Moyer, and I.L. Cameron Efficacy of treatment of colon, lung and breast human carcinoma xenografts with: doxorubicin, cisplatin, irinotecan or topotecan Anticancer Res 19 1999 2269 2274
-
(1999)
Anticancer Res
, vol.19
, pp. 2269-2274
-
-
Hardman, W.E.1
Moyer, M.P.2
Cameron, I.L.3
-
19
-
-
0029986515
-
Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro
-
C.M. Kurbacher, U. Wagner, B. Kolster, P.E. Andreotti, D. Krebs, and H.W. Bruckner Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro Cancer Lett 103 1996 183 189
-
(1996)
Cancer Lett
, vol.103
, pp. 183-189
-
-
Kurbacher, C.M.1
Wagner, U.2
Kolster, B.3
Andreotti, P.E.4
Krebs, D.5
Bruckner, H.W.6
-
20
-
-
0034086039
-
1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death
-
Q. Wang, W. Yang, M.S. Uytingco, S. Christakos, and R. Wieder 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death Cancer Res 60 2000 2040 2048
-
(2000)
Cancer Res
, vol.60
, pp. 2040-2048
-
-
Wang, Q.1
Yang, W.2
Uytingco, M.S.3
Christakos, S.4
Wieder, R.5
-
21
-
-
0032970814
-
Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways
-
W. Nieves-Neira, and Y. Pommier Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways Int J Cancer 82 1999 396 404
-
(1999)
Int J Cancer
, vol.82
, pp. 396-404
-
-
Nieves-Neira, W.1
Pommier, Y.2
-
22
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
23
-
-
3543071500
-
Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: Contrasting roles of FOXN1 and Akt
-
[2004]
-
S.M. Janes, T.A. Ofstad, D.H. Campbell, F.M. Watt, and D.M. Prowse Transient activation of FOXN1 in keratinocytes induces a transcriptional programme that promotes terminal differentiation: contrasting roles of FOXN1 and Akt J Cell Sci 117 2004 4157 4168 [2004]
-
(2004)
J Cell Sci
, vol.117
, pp. 4157-4168
-
-
Janes, S.M.1
Ofstad, T.A.2
Campbell, D.H.3
Watt, F.M.4
Prowse, D.M.5
-
24
-
-
34250187067
-
Cytokinesis-block micronucleus cytome assay
-
M. Fenech Cytokinesis-block micronucleus cytome assay Protoc Nat Protoc 2 2007 1088 1104
-
(2007)
Protoc Nat Protoc
, vol.2
, pp. 1088-1104
-
-
Fenech, M.1
-
26
-
-
0032508529
-
P130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon
-
N.S. Thomas, A.R. Pizzey, S. Tiwari, C.D. Williams, and J. Yang p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon J Biol Chem 273 1998 23659 23667
-
(1998)
J Biol Chem
, vol.273
, pp. 23659-23667
-
-
Thomas, N.S.1
Pizzey, A.R.2
Tiwari, S.3
Williams, C.D.4
Yang, J.5
-
27
-
-
69449095652
-
Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses
-
E.G. Konstantakou, G.E. Voutsinas, P.K. Karkoulis, G. Aravantinos, L.H. Margaritis, and D.J. Stravopodis Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses Int J Oncol 35 2009 401 416
-
(2009)
Int J Oncol
, vol.35
, pp. 401-416
-
-
Konstantakou, E.G.1
Voutsinas, G.E.2
Karkoulis, P.K.3
Aravantinos, G.4
Margaritis, L.H.5
Stravopodis, D.J.6
-
28
-
-
0026742542
-
Antiproliferative potencies of interferons on melanoma cell lines and xenografts: Higher efficacy of interferon beta
-
T.G. Johns, I.R. Mackay, and K.A. Callister Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon beta J Natl Cancer Inst 84 1992 1185 1190
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1185-1190
-
-
Johns, T.G.1
Mackay, I.R.2
Callister, K.A.3
-
29
-
-
84894555725
-
Influence of type-I interferon receptor expression level on the response to type-I interferons in human pancreatic cancer cells
-
B. Stephanie, H.J. Casper, D. Fadime, M.K. Peter, and J.H. Leo Influence of type-I interferon receptor expression level on the response to type-I interferons in human pancreatic cancer cells J Cell Mol Med 18 3 2014 492 502
-
(2014)
J Cell Mol Med
, vol.18
, Issue.3
, pp. 492-502
-
-
Stephanie, B.1
Casper, H.J.2
Fadime, D.3
Peter, M.K.4
Leo, J.H.5
-
30
-
-
78650664775
-
Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells
-
M. Fenech, V.M. Kirsch, A.T. Natarajan, J. Surralles, J.W. Crott, and J. Parry Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells Mutagenesis 26 1 2011 125 132
-
(2011)
Mutagenesis
, vol.26
, Issue.1
, pp. 125-132
-
-
Fenech, M.1
Kirsch, V.M.2
Natarajan, A.T.3
Surralles, J.4
Crott, J.W.5
Parry, J.6
-
31
-
-
33847737716
-
DNA damage checkpoints: From initiation to recovery or adaptation
-
J. Bartek, and J. Lukas DNA damage checkpoints: from initiation to recovery or adaptation Curr Opin Cell Biol 19 2007 238 245
-
(2007)
Curr Opin Cell Biol
, vol.19
, pp. 238-245
-
-
Bartek, J.1
Lukas, J.2
-
32
-
-
33846821915
-
P53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage
-
H.C. Reinhardt, A.S. Aslanian, J.A. Lees, and M.B. Yaffe p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage Cancer Cell 11 2007 175 189
-
(2007)
Cancer Cell
, vol.11
, pp. 175-189
-
-
Reinhardt, H.C.1
Aslanian, A.S.2
Lees, J.A.3
Yaffe, M.B.4
-
33
-
-
65649115821
-
Chromosomal aberration and micronucleus studies of two topoisomerase (II) targeting anthracyclines
-
K. Fauzia, F.S. Asma, and A. Mohammad Chromosomal aberration and micronucleus studies of two topoisomerase (II) targeting anthracyclines J Environ Biol 30 3 2009 409 412
-
(2009)
J Environ Biol
, vol.30
, Issue.3
, pp. 409-412
-
-
Fauzia, K.1
Asma, F.S.2
Mohammad, A.3
-
34
-
-
0036176510
-
Mechanisms of cancer drug resistance
-
M.M. Gottesman Mechanisms of cancer drug resistance Annu Rev Med 53 2002 615 627
-
(2002)
Annu Rev Med
, vol.53
, pp. 615-627
-
-
Gottesman, M.M.1
-
35
-
-
0344393783
-
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
-
S.H. Kaufmann, and D.L. Vaux Alterations in the apoptotic machinery and their potential role in anticancer drug resistance Oncogene 22 2003 7414 7430
-
(2003)
Oncogene
, vol.22
, pp. 7414-7430
-
-
Kaufmann, S.H.1
Vaux, D.L.2
-
36
-
-
0032575688
-
The Bcl-2 protein family: Arbiters of cell survival
-
J.M. Adams, and S. Cory The Bcl-2 protein family: arbiters of cell survival Science 281 1998 1322 1326
-
(1998)
Science
, vol.281
, pp. 1322-1326
-
-
Adams, J.M.1
Cory, S.2
-
37
-
-
0034895641
-
Preferential induction of apoptosis by interferon IFN-β compared with IFN-α correlation with TRAIL/Apo2L induction in melanoma cell lines
-
M. Chawla-Sarkar, D.W. Leaman, and E.C. Borden Preferential induction of apoptosis by interferon IFN-β compared with IFN-α correlation with TRAIL/Apo2L induction in melanoma cell lines Clin Cancer Res 7 2001 1821
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1821
-
-
Chawla-Sarkar, M.1
Leaman, D.W.2
Borden, E.C.3
-
38
-
-
33845977959
-
Mitochondrial membrane permeabilisation in cell death
-
G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial membrane permeabilisation in cell death Physiol Rev 87 1 2007 99 116
-
(2007)
Physiol Rev
, vol.87
, Issue.1
, pp. 99-116
-
-
Kroemer, G.1
Galluzzi, L.2
Brenner, C.3
-
39
-
-
68249142906
-
Identification and characterization of the interferon-b-mediated p53 signal pathway in human peripheral blood mononuclear cells
-
F. Zhang, and S. Sriram Identification and characterization of the interferon-b-mediated p53 signal pathway in human peripheral blood mononuclear cells Immunology 128 2009 905 918.
-
(2009)
Immunology
, vol.128
, pp. 905-918
-
-
Zhang, F.1
Sriram, S.2
|